Press "Enter" to skip to content

New patent expiration for Allergan drug ALPHAGAN P

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Allergan drug ALPHAGAN P

Annual Drug Patent Expirations for ALPHAGAN+P
Annual Drug Patent Expirations for ALPHAGAN+P

Alphagan P is a drug marketed by Allergan and is included in two NDAs. It is available from one supplier. There are eight patents protecting this drug and two Paragraph IV challenges.

ALPHAGAN P drug price trends.

Drug patent litigation for ALPHAGAN P.

This drug has thirty-eight patent family members in nineteen countries.

The generic ingredient in ALPHAGAN P is brimonidine tartrate. One supplier is listed for this compound. Additional details are available on the brimonidine tartrate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Allergan drug ALPHAGAN P
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions